Olenox Industries, Inc. to acquire Psylinks Neurotech Corp.

Olenox Industries, Inc. has agreed to acquire Psylinks Neurotech Corp. in a strategic acquisition valued at USD 500,000. The transaction, announced and completed on 3 July 2026, involves consideration paid through shares. Olenox is based in the United States, while the target company operates from Canada. This deal represents a cross-border consolidation within the technology sector, bringing together two entities to combine their respective capabilities and market presence. The structure of the deal relies entirely on equity exchange, with no cash component reported in the available data.

The acquisition marks the completion of the transaction between the US-based industrial technology firm and the Canadian neurotech specialist. Both parties have finalised the necessary steps to close the deal on the same day it was publicly announced. This rapid execution suggests a pre-arranged agreement between the management teams and shareholders of both organisations. The transaction is now fully integrated, with Olenox Industries, Inc. owning Psylinks Neurotech Corp. outright. The deal concludes a period of negotiation and due diligence, establishing a new corporate structure under the larger parent entity. Regulatory approvals were secured prior to the completion date, ensuring a smooth transition of ownership and operational control.